Q1 2025

Showing 1034 articles
Business

IDEXX Laboratories Posts Strong Q4 Growth, Unveils Ambitious 2026 Outlook on Diagnostic Innovation

IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.

Business

Investors Pull Record $1.73B From Crypto Funds as Rate Cut Hopes Fade

Digital asset investment products witnessed their largest weekly capital flight since late 2025, with Bitcoin and Ethereum bearing the brunt of a $1.73 billion exodus. The sell-off, concentrated in the U.S., underscores a sharp pivot in risk appetite amid shifting macroeconomic winds, though Solana and select regions bucked the trend with modest inflows.